Investors are encouraged to submit questions in advance to IR@fusion-fuel.eu by May 19, 2026.
Fusion Fuel Overview: Highlights of the business, recent developments, details of the QIND transaction, group targets, and NASDAQ compliance. Al Shola Gas Business Update: Overview of Al Shola’s ...
SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present ...
Title: Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Session: Late-Breaking Poster Session 2871-LB Presenter: Mini Balakrishnan, Ph.D. Date/Time: June 7, 2026, at 12:30 ...
Preliminary data demonstrate FPI-2265 is active in heavily pretreated patients with progressive metastatic castration-resistant prostate cancer (mCRPC), including those who received prior ...